The incidence of malignant disease in patients receiving cytotoxic therapy for rheumatoid arthritis.
AUTOR(ES)
Kirsner, A B
RESUMO
One hundred and twenty-six patients with definite or classical rheumatoid arthritis admitted to hospital between 1965 and 1974 for cytotoxic therapy were studied for the presence and type of malignant disease. Each of the cytotoxic treated patients was age and sex matched to a rheumatoid arthritis patient admitted to hospital during the same years but who did not receive cytotoxic therapy. There was no increase in malignancy in the cytotoxic treated group over the control group.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1030291Documentos Relacionados
- Reduction of peripheral blood lymphocytes in patients receiving gold therapy for rheumatoid arthritis.
- Incidence of arteriosclerosis in patients with rheumatoid arthritis receiving long-term corticosteroid therapy.
- Liver histology in patients receiving low dose pulse methotrexate for the treatment of rheumatoid arthritis.
- Adjuvant oestrogen therapy does not improve disease activity in postmenopausal patients with rheumatoid arthritis.
- Cytokine therapy in rheumatoid arthritis.
